Tochigi, Japan

Hiroyuki Ebisu


Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1998-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hiroyuki Ebisu: Innovator in Antimicrobial Research

Introduction

Hiroyuki Ebisu is a notable inventor based in Tochigi, Japan. He has made significant contributions to the field of antimicrobial research, holding 2 patents that showcase his innovative approach to combating infectious diseases. His work focuses on developing novel compounds that exhibit potent antimicrobial properties.

Latest Patents

One of his latest patents is titled "Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position." This invention aims to provide a novel mutilin derivative with a substitution at the 14-position, which is a new mutilin analogue exhibiting a potent and broad antimicrobial action against both Gram-positive and Gram-negative bacteria, including various drug-resistant strains. This compound is expected to be useful as an agent for treating infectious diseases. Another significant patent is for "Acrylamide derivatives and process for production thereof," which further emphasizes his commitment to advancing pharmaceutical research.

Career Highlights

Hiroyuki Ebisu has worked with prominent companies in the pharmaceutical industry, including Kyorin Pharmaceutical Co., Ltd. and Sagami Chemical Research Center. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of antimicrobial therapies.

Collaborations

Throughout his career, Hiroyuki has collaborated with esteemed colleagues such as Yasumichi Fukuda and Shigeki Seto. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of antimicrobial research.

Conclusion

Hiroyuki Ebisu's contributions to antimicrobial research through his patents and collaborations highlight his dedication to improving public health. His innovative work continues to pave the way for new treatments against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…